Journal Article

Fecal DNA Testing of TWIST1 Methylation Identifies Patients With Advanced Colorectal Adenoma Missed by Fecal Immunochemical Test for Hemoglobin

Yamamoto, Naoki, Koga, Michiko, Yoshida, Shin, Suzuki, Chieko, Hoshida, Tomomi, Yotsuyanagi, Hiroshi, Yamaoka, Yuko, Higaki, Shingo, Lim, Lay Ahyoung, Nagano, Hiroaki, Hashimoto, Shinichi, Hazama, Shoichi, Yamasaki, Takahiro, Suzuki, Nobuaki, Tsutsumi, Takeya, Matsumoto, Toshihiko, Suehiro, Yutaka, Goto, Atsushi, Matsubara, Yasuo, Fujii, Ikuei, Takami, Taro, Sakaida, Isao

2020

Overview

We have reported previously that fecal DNA testing of TWIST1 methylation in combination with the fecal immunochemical test for hemoglobin (FIT) (combination test) is useful for colorectal neoplasia screening. In this study, using larger sample sizes, we studied the clinical performance of the combination test for the detection of colorectal neoplasia and, especially, advanced colorectal adenoma. We performed a prospective study in which FIT, fecal DNA testing of TWIST1 methylation, and colonoscopy were performed on 372 patients with colorectal neoplasia and 71 subjects without colorectal neoplasia. We assessed the individual clinical performance of each of FIT and fecal DNA testing of TWIST1 methylation and of the combination test for the detection of colorectal neoplasia including advanced adenoma based on morphologic subtypes. The FIT alone had a sensitivity of 7.5% (3/40) for nonadvanced adenoma, 32.3% (41/127) for advanced adenoma, and 93.7% (192/205) for colorectal cancer and a specificity of 87.3% (62/71). The combination test had a sensitivity of 35.0% (14/40) for nonadvanced adenoma, 68.5% (87/127) for advanced adenoma, and 95.6% (196/205) for colorectal cancer and a specificity of 80.3% (57/71). For morphological subtypes of advanced adenoma, the sensitivity of FIT was only 28.2% (20/71) for polypoid type and 16.1% (5/31) for nonpolypoid type, whereas the combination test increased the sensitivities to 64.8% (46/71) and 71.0% (22/31), respectively. The combination of the fecal DNA test with FIT seemed to be useful to detect colorectal neoplasia and, especially, advanced adenoma of the nonpolypoid type.

• Publisher: Wolters Kluwer,Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins
• Subject: Adenoma - diagnosis / Adenoma - genetics / Adult / Aged / Aged, 80 and over / Biomarkers, Tumor - analysis / Biomarkers, Tumor - genetics / Colonoscopy / Colorectal cancer / Colorectal Neoplasms - diagnosis / Colorectal Neoplasms - genetics / Deoxyribonucleic acid / DNA / DNA - genetics / DNA - isolation & purification / DNA Methylation / Feces / Feces - chemistry / Female / Genetic testing / Hemoglobin / Hemoglobins - analysis / Hospitals / Humans / Lymphoma / Male / Medical screening / Middle Aged / Nuclear Proteins - analysis / Nuclear Proteins - genetics / Polymerase chain reaction / Prospective Studies / Sensitivity and Specificity / Tumors / Twist-Related Protein 1 - analysis / Twist-Related Protein 1 - genetics